- Conditions
- Intervertebral Disc Degeneration, Osteoarthritis, Spine
- Interventions
- EOS imaging
- Radiation
- Lead sponsor
- University of Colorado, Denver
- Other
- Eligibility
- 21 Years to 85 Years
- Enrollment
- 60 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2016 – 2031
- U.S. locations
- 1
- States / cities
- Aurora, Colorado
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 284
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Demographic Data, History of Medical and Mental Health, History of Combat Experience, History of Suicide, Imaging Results
- Interventions
- Not listed
- Lead sponsor
- VA Eastern Colorado Health Care System
- Federal
- Eligibility
- 18 Years and older
- Enrollment
- 5,000 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2026
- U.S. locations
- 2
- States / cities
- Denver, Colorado
- Conditions
- Ileus
- Interventions
- Alvimopan
- Drug
- Lead sponsor
- Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 7,050 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010
- U.S. locations
- 1
- States / cities
- Charlotte, North Carolina
- Conditions
- Healthy Eyes
- Interventions
- MAIA
- Device
- Lead sponsor
- Centervue SpA
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 380 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2026
- U.S. locations
- 1
- States / cities
- Fort Lauderdale, Florida
- Conditions
- Amyotrophic Lateral Sclerosis, Neurodegenerative Disease, Motor Neuron Disease
- Interventions
- Not listed
- Lead sponsor
- Drexel University College of Medicine
- Other
- Eligibility
- 18 Years to 89 Years
- Enrollment
- 25 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2015
- U.S. locations
- 1
- States / cities
- Philadelphia, Pennsylvania
- Conditions
- Determination of Neurological Outcomes
- Interventions
- Fetal intervention
- Procedure
- Lead sponsor
- Baylor College of Medicine
- Other
- Eligibility
- Not listed
- Enrollment
- 2,000 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2030
- U.S. locations
- 1
- States / cities
- Houston, Texas
- Conditions
- Pregnancy, Cancer, Cancer in Pregnancy, Gestational Breast Cancer, Pregnancy Related
- Interventions
- Not listed
- Lead sponsor
- The Cooper Health System
- Other
- Eligibility
- Female only
- Enrollment
- 400 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2003 – 2025
- U.S. locations
- 1
- States / cities
- Camden, New Jersey
- Conditions
- Hysterectomy
- Interventions
- Hysteroscopic device placement including Essure (ESS305, BAY1454032), Tubal ligation
- Device · Procedure
- Lead sponsor
- Bayer
- Industry
- Eligibility
- 18 Years to 49 Years · Female only
- Enrollment
- 10,578 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015
- U.S. locations
- 1
- States / cities
- New Jersey, New Jersey
- Conditions
- Cancer of Liver, Pancreatic Cancer, Biliary Tract Cancer
- Interventions
- HPB Surgery
- Procedure
- Lead sponsor
- Wake Forest University Health Sciences
- Other
- Eligibility
- 18 Years to 90 Years
- Enrollment
- 74 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2017
- U.S. locations
- 1
- States / cities
- Charlotte, North Carolina
- Conditions
- Biliary Atresia
- Interventions
- Not listed
- Lead sponsor
- Arbor Research Collaborative for Health
- Other
- Eligibility
- Up to 6 Months
- Enrollment
- 1,000 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2029
- U.S. locations
- 15
- States / cities
- Los Angeles, California • San Francisco, California • Aurora, Colorado + 12 more
- Conditions
- Niemann-Pick Disease, Type C
- Interventions
- Not listed
- Lead sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- NIH
- Eligibility
- 3 Months and older
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2026
- U.S. locations
- 1
- States / cities
- Bethesda, Maryland
- Conditions
- Pregnancy Related, Pregnancy Complications, Pregnancy, High Risk
- Interventions
- Relugolix + Estradiol + Norethindrone Acetate
- Drug
- Lead sponsor
- Sumitomo Pharma Switzerland GmbH
- Industry
- Eligibility
- 18 Years to 50 Years · Female only
- Enrollment
- 530 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 1
- States / cities
- Marlborough, Massachusetts
- Conditions
- Cardiovascular Diseases
- Interventions
- Not listed
- Lead sponsor
- Kenneth S. Campbell
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 400 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2030
- U.S. locations
- 1
- States / cities
- Lexington, Kentucky
- Conditions
- Heart Diseases, Heart Failure, Heart Defects, Congenital
- Interventions
- SherpaPak Cardiac Transport System
- Device
- Lead sponsor
- Paragonix Technologies
- Industry
- Eligibility
- Not listed
- Enrollment
- 3,000 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2029
- U.S. locations
- 17
- States / cities
- Stanford, California • Washington D.C., District of Columbia • Gainesville, Florida + 13 more
- Conditions
- Atherosclerotic Cardiovascular Disease, Familial Hypercholesterolemia
- Interventions
- Not listed
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 37,688 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2024
- U.S. locations
- 1
- States / cities
- East Hanover, New Jersey
- Conditions
- Tuberous Sclerosis, Lymphangioleiomyomatosis
- Interventions
- Phlebotomy, Buccal (cheek) swab, Genetic Testing, Tissue donation after routine clinical procedure
- Procedure · Genetic · Other
- Lead sponsor
- National Tuberous Sclerosis Association
- Other
- Eligibility
- Not listed
- Enrollment
- 5,000 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2050
- U.S. locations
- 24
- States / cities
- Birmingham, Alabama • Loma Linda, California • Los Angeles, California + 19 more
- Conditions
- Prostate Cancer
- Interventions
- Prostate Ablation
- Procedure
- Lead sponsor
- University of Chicago
- Other
- Eligibility
- 22 Years and older · Male only
- Enrollment
- 3,000 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2029
- U.S. locations
- 2
- States / cities
- Hyde Park, Illinois • Cincinnati, Ohio
- Conditions
- Transthyretin Cardiac Amyloidosis, Transthyretin Amyloid Cardiomyopathy
- Interventions
- 99mTc-pyrophosphate Single Photon Emission Computed Tomography
- Diagnostic Test
- Lead sponsor
- Montefiore Medical Center
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 476 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2026
- U.S. locations
- 1
- States / cities
- The Bronx, New York
- Conditions
- Kinematics
- Interventions
- Joint Motion Analysis
- Behavioral
- Lead sponsor
- University of Florida
- Other
- Eligibility
- 2 Years to 75 Years
- Enrollment
- 10,000 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2005 – 2027
- U.S. locations
- 1
- States / cities
- Gainesville, Florida
- Conditions
- Orthopedic Disorder
- Interventions
- Orthobiologic Procedures
- Procedure
- Lead sponsor
- Regenexx, LLC
- Industry
- Eligibility
- Not listed
- Enrollment
- 50,000 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2036
- U.S. locations
- 30
- States / cities
- Phoenix, Arizona • Beverly Hills, California • Oceanside, California + 26 more
- Conditions
- Hypertension
- Interventions
- Metoprolol, Nebivolol
- Drug
- Lead sponsor
- Forest Laboratories
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 3,000 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2013
- U.S. locations
- 1
- States / cities
- Jersey City, New Jersey
- Conditions
- Chronic Thromboembolic Pulmonary Hypertension, CTEPH
- Interventions
- Not listed
- Lead sponsor
- International CTEPH Association
- Other
- Eligibility
- Not listed
- Enrollment
- 1,019 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2020
- U.S. locations
- 3
- States / cities
- La Jolla, California • Baltimore, Maryland • Cleveland, Ohio
- Conditions
- Advanced Breast Cancer
- Interventions
- Initiation of abemaciclib plus letrozole/anastrozole, Initiation of letrozole/anastrozole
- Drug
- Lead sponsor
- Brigham and Women's Hospital
- Other
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 3,883 participants
- Timeline
- 2025 – 2026
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Prostatic Neoplasm
- Interventions
- Xofigo (Radium 223 dichloride,BAY88-8223)
- Drug
- Lead sponsor
- Bayer
- Industry
- Eligibility
- 45 Years and older · Male only
- Enrollment
- 565 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2017
- U.S. locations
- 1
- States / cities
- Whippany, New Jersey